Skip to main content
Clinical Trials/IRCT20210622051666N1
IRCT20210622051666N1
Recruiting
Phase 3

Evaluation of oral N-acetylcysteine efficacy versus placebo in prevention of mucositis induced by radiotherapy and chemotherapy agents in children with malignancy A double blind randomized clinical trial

Ahvaz University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are 2\-18 years old
  • Recipients of radiotherapy and anti\-metabolite chemotherapy drugs with a high risk of developing oral mucositis (including Doxorubicin, Methotrexate, FU Etoposide, Cytarabine and Melphalan) and other drugs listed below.
  • Patients with lansky performance scale index above 70%
  • No Cardiovascular disease

Exclusion Criteria

  • Causes any severe allergic reactions to the drug (such as skin complications, bronchospasm, bronchitis, etc.)
  • Any active gastrointestinal disease
  • Cardiovascular disease

Outcomes

Primary Outcomes

Not specified

Similar Trials